Ticker Details
Rhythm Pharmaceuticals, Inc. Rhythm Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of peptide therapeutics for the treatment of gastrointestinal, or GI, diseases, and genetic deficiencies that result in metabolic disorders.
IPO Date:	October 5, 2017
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$6.02B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.89 | 2.87%
Avg Daily Range (30 D):	$1.64 | 1.84%
Avg Daily Range (90 D):	$2.35 | 2.49%

Institutional Daily Volume
Avg Daily Volume:	.43M
Avg Daily Volume (30 D):	.57M
Avg Daily Volume (90 D):	.65M

Trade Size
Avg Trade Size (Sh.):	67
Avg Trade Size (Sh.) (30 D):	51
Avg Trade Size (Sh.) (90 D):	53

Institutional Trades
Total Institutional Trades:	3,179
Avg Institutional Trade:	$2.89M
Avg Institutional Trade (30 D):	$3.9M
Avg Institutional Trade (90 D):	$4.48M
Avg Institutional Trade Volume:	.07M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$4.26M
Avg Closing Trade (30 D):	$7.96M
Avg Closing Trade (90 D):	$9.27M
Avg Closing Volume:	101.87K

News

May 26, 2026 @ 12:00 PM Rhythm Pharmaceuticals Announces Participation in ... Source: Rhythm Pharmaceuticals, Inc.

May 14, 2026 @ 9:25 AM Green Thumb Just Made an Unprecedented Move. Here'... Source: Keith Speights

Apr 3, 2026 @ 1:00 PM Rhythm Pharmaceuticals Announces Changes to Board ... Source: Na

Mar 19, 2026 @ 10:30 PM Rhythm Pharmaceuticals Announces FDA Approval of I... Source: Rhythm Pharmaceuticals, Inc.

Mar 17, 2026 @ 12:33 PM Stock Market Today: Dow, S&P 500 Futures Tick Up A... Source: Rishabh Mishra

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-3.13	$-.83	$-.73
Diluted EPS	$-3.13	$-.83	$-.73
Revenue	$217.17M	$60.11M	$57.25M
Gross Profit	$194.16M	$52.96M	$52.45M
Net Income / Loss	$-202.68M	$-55.64M	$-47.51M
Operating Income / Loss	$-197.37M	$-52.36M	$-47.06M
Cost of Revenue	$23M	$7.16M	$4.8M
Net Cash Flow	$-44.36M	$7.47M	$2.01M
PE Ratio